The Effect of Radiation Therapy after Radical Prostatectomy in Patients with Elevated Prostate Specific Antigen Levels (Q67670426)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1697918%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

title

The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1697918%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

The Effect of Radiation Therapy after Radical Prostatectomy in Patients with Elevated Prostate Specific Antigen Levels (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

1 November 2022

2

D J Lightner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1697918%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

author name string

P. H. Lange

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1697918

1 November 2022

E. Medini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1697918

1 November 2022

P. K. Reddy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1697918

1 November 2022

R. L. Vessella

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1697918

1 November 2022

language of work or name

English

0 references

publication date

1 October 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1697918%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

16 September 2019

https://api.elsevier.com/content/article/PII:S0022534717396246?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

https://api.elsevier.com/content/article/PII:S0022534717396246?httpAccept=text/plain

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2939624-6

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

1 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1697918%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

volume

144

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1697918%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1697918%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

page(s)

927-32; discussion 932-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1697918%20AND%20SRC:MED&resulttype=core&format=json

External beam radiation salvage for residual or recurrent local tumor following radical prostatectomy

16 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Adjuvant radiotherapy following radical prostatectomy: results and complications

1 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Postoperative irradiation in carcinoma of the prostate

1 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

The role of external beam radiation therapy after prostatectomy for prostate cancer

1 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Definitive radiotherapy following prostatectomy: results and complications

1 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule.

1 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Postoperative radiation therapy for pathologic stage C prostate cancer

1 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Radical Prostatectomy in Stage a Prostatic Adenocarcinoma

1 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Adjuvant radiation therapy in stages C and D1 prostatic adenocarcinoma: preliminary results

1 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Intermediate-Term Survival Results in Clinically Understaged Prostate Cancer Patients Following Radical Prostatectomy

1 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Adjuvant radiotherapy after radical prostatectomy: is it indicated?

1 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Radiation therapy as adjuvant treatment after radical prostatectomy

1 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Staging errors in clinically localized prostatic cancer

1 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Understaging and undergrading of prostate cancer. Argument for postoperative radiation as adjuvant therapy

1 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Prognostic factors in localized prostatic carcinoma.

1 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer

1 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.

1 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients

1 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients

1 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients

1 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients

1 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

The value of serum prostate specific antigen determinations before and after radical prostatectomy

1 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Prostate Specific Antigen and Local Recurrence after Radical Prostatectomy

1 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Technical nuances and surgical results of radical retropubic prostatectomy in 150 patients

1 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Radical prostatectomy for stage D1 prostate cancer. Prognostic variables and results of treatment

1 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Treatment options for patients with stage D1 (T0-3,N1-2,M0) adenocarcinoma of prostate

1 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Management of Stage D1 Adenocarcinoma of the Prostate: The Johns Hopkins Experience 1974 to 1987

1 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Effect of Adjuvant Radiation Therapy on Prostate Specific Antigen Following Radical Prostatectomy

1 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

1 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

Effects of external radiation therapy for cancer of the prostate on the serum concentrations of testosterone, follicle-stimulating hormone, luteinizing hormone and prolactin

1 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

The effects of external beam radiotherapy on endocrine function in patients with carcinoma of the prostate

1 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)39624-6

1 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1697918%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

1 reference